Sign in
4

Changes in Ownership

Xenon Pharmaceuticals Inc. Filed Acc 0000950170-24-030226

Options or other derivatives

  • PRESIDENT & CEO acquired 250,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

MORTIMER IAN · PRESIDENT & CEO

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-03-11 Grant or award : show line 1 in the form Stock Option (Right to Buy) +250,000 250,000 D
Loading xslF345X05/ownership.xml…